Abstract:: Regulatory T cells (Treg) is a vital cell subset inducing immune tolerance in tumor microenvironment by secreting suppressive cytokines and inhibit innate immune cells. Transforming growth factor-β (TGF-β) plays an important role in this process because both the differentiation and functioning of Treg are relied on it. Elevated Tregs and TGF-β in pancreatic ductal adenocarcinoma (PDAC) microenvironment was previously explored with a protein expression array. In this study, we evaluated the quantity and quality change of Treg after neutralizing TGF-β with different doses of monoclonal antibody 1D11: the tumor volume was measured, the T cell subsets was assessed by flow cytometry in peripheral blood and spleen and was stained by immunohistochemistry in tumor, and main cytokines in tumor tissue were detected by enzyme linked immunosorbent assay in a murine PDAC model. As a result, only tumor infiltrating Tregs decreased significantly (high dose, low dose and control, 38.6±8.1, 38.6±1.8, 74.6±4.9/40× field, P=0.024) after 1D11 administration, the CD8+ T cells in the tumor microenvironment elevated in the low-dose group but remain almost the same level in the high-dose group (high dose, low dose and control, 3.1±11.9, 12.3±2.1, 5.4±0.5/40× field, P=0.016). The frequency of CD4+, CD8+ or Treg in peripheral blood and spleen showed no significant change and the typical cytokines TGF-β and inerleukin-10 secreted by Tregs and interferon-γ produced by T cells in tumor tissue also remained at the same level as untreated. In conclusion, this research indicated neutralizing TGF-β with monoclonal antibody can reduce Tregs in tumor niche, however, the functional alteration should still be evaluated in further studies.

Treg suppressing CTL anti-gastric cancer effect by restraining perforin and IFN-γ releasing

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

The influence of enriched CD4+CD25+ T regulatory cells on cytotoxic T lymphocytes killing MNK45 cells in vitro and its possible mechanism

Effects of CD4+CD25+ regulatory T cells on adoptive immunotherapy effector cells of colon carcinoma

Regulatory T cells regulate function of effector T lymphocytes in tumor-draining lymph node of mouse hepatocelluar carcinoma

Effect of blocking the transforming growth factor-beta signaling pathway on tumor-specific cytotoxic T lym-phocytes

Mechanism of the Immune Suppression Mediated by Regulatory T Cells in the Microenvironment of Gastric Cancer

The suppressive effect of CD25 +Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production

[Influence of CD4+ and CD25+ T Regulatory Cell on Mouse Bearing Gastric Tumor in Vivo].

Effects of the Microenvironment of Irradiated Tumor Cells on Treg Cells and Related Regulation Factors

Inhibitory effect of CD4+CD25+CCR6+ regulatory T cells against CD8+T cells in mouse mammary carcinoma model

Detection of Different Cytokines of the CD4 + CD25 + Regulatory T Cells in Peripheral Blood of Gastric Cancer Patients and Implication0

Effects of IL-2 and IL-10 on T regulatory cell proliferation in vitro

Treg Depletion Enhances the DC/HCC Fusion Vaccine to Induce Antitumor Immune Responses Against Hepatocellular Carcinoma

AB037. P008. Intratumoral Regulatory T Cells (tregs) Reduced by Neutralization TGF-β in Murine Pancreatic Ductal Adenocarcinoma Model Without Promising Functional Change

Profile of Regulatory T Cells and Interferon Γ Secretion in the Tumor-Draining Lymph Node from Mouse Hepa1–6 Cells

Regulatory T Cell and Tumor Immunity

Interaction between regulatory T cells and mast cells via IL-9 and TGF-β production

Expression and Clinical Significance of Regulatory T Cells in Patients with Colon Cancer

IL-2-deprivation and TGF-β are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25− cell activation

CD4+CD25+Foxp3+ Regulatory T Cells Suppress NKG2D-mediated NK Cell Cytotoxicity in Peripheral Blood.